← Back to WGS

GeneDx Holdings Corp. - Class A Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 03/08/2026Mar 2026Filed 04/05/2026Sep 2025Filed 28/10/2025Jun 2025Filed 03/08/2026Mar 2025Filed 04/05/2026Sep 2024Filed 28/10/2025Jun 2024Filed 29/07/2025Mar 2024Filed 30/04/2025
$114$102$117$103$87$77$71$62
−$18−$63−$7.6$11−$6.5−$8.3−$29−$20
−$0.60−$2.16−$0.27$0.36−$0.23−$0.31−$1.10−$0.78
3029293028272726

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.